181 related articles for article (PubMed ID: 6358053)
1. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Bhan AK
Int J Cancer; 1983 Nov; 32(5):547-54. PubMed ID: 6358053
[TBL] [Abstract][Full Text] [Related]
2. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
Bhan AK; DesMarais CL
J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
[TBL] [Abstract][Full Text] [Related]
3. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
Whitwell HL; Hughes HP; Moore M; Ahmed A
Br J Cancer; 1984 Feb; 49(2):161-72. PubMed ID: 6365133
[TBL] [Abstract][Full Text] [Related]
4. Distribution of major histocompatibility antigens in normal skin.
Harrist TJ; Ruiter DJ; Mihm MC; Bhan AK
Br J Dermatol; 1983 Dec; 109(6):623-33. PubMed ID: 6360195
[TBL] [Abstract][Full Text] [Related]
5. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms.
Csiba A; Whitwell HL; Moore M
Br J Cancer; 1984 Nov; 50(5):699-709. PubMed ID: 6238615
[TBL] [Abstract][Full Text] [Related]
6. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.
Bergman W; Willemze R; de Graaff-Reitsma C; Ruiter DJ
J Invest Dermatol; 1985 Jul; 85(1):25-9. PubMed ID: 3159801
[TBL] [Abstract][Full Text] [Related]
7. Implantation site in normal pregnancy. A study with monoclonal antibodies.
Kabawat SE; Mostoufi-Zadeh M; Driscoll SG; Bhan AK
Am J Pathol; 1985 Jan; 118(1):76-84. PubMed ID: 3155596
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of seminoma and its inflammatory cell infiltrate.
Bell DA; Flotte TJ; Bhan AK
Hum Pathol; 1987 May; 18(5):511-20. PubMed ID: 3552955
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.
Ruiter DJ; Bhan AK; Harrist TJ; Sober AJ; Mihm MC
J Immunol; 1982 Dec; 129(6):2808-15. PubMed ID: 6183345
[TBL] [Abstract][Full Text] [Related]
10. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Colvin RB
Am J Clin Pathol; 1983 Jan; 79(1):98-104. PubMed ID: 6336888
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
Yamada K; Ohkawa K; Joh K
Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
[TBL] [Abstract][Full Text] [Related]
12. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor-associated antigens.
Bhattacharya M; Barlow JJ
Cancer; 1973 Mar; 31(3):588-95. PubMed ID: 4632680
[No Abstract] [Full Text] [Related]
13. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.
Lloyd RV; Johnson TL; Blaivas M; Sisson JC; Wilson BS
Am J Pathol; 1985 Jul; 120(1):106-11. PubMed ID: 3893150
[TBL] [Abstract][Full Text] [Related]
14. The immunohistochemical demonstration of major histocompatibility antigens in the human kidney using monoclonal antibodies.
Hancock WW; Kraft N; Atkins RC
Pathology; 1982 Oct; 14(4):409-14. PubMed ID: 6760089
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells.
Boyer CM; Borowitz MJ; McCarty KS; Kinney RB; Everitt L; Dawson DV; Ring D; Bast RC
Int J Cancer; 1989 Jan; 43(1):55-60. PubMed ID: 2463226
[TBL] [Abstract][Full Text] [Related]
16. Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers.
Le YS; Kim TE; Kim BK; Park YG; Kim GM; Jee SB; Ryu KS; Kim IK; Kim JW
Exp Mol Med; 2002 Mar; 34(1):18-26. PubMed ID: 11989974
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.
Zuk JA; Walker RA
J Pathol; 1987 Aug; 152(4):275-85. PubMed ID: 3312546
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of HLA-DR antigen in serous ovarian tumors.
Tamiolakis D; Kotini A; Venizelos J; Jivannakis T; Simopoulos C; Papadopoulos N
Clin Exp Med; 2003 Sep; 3(2):113-8. PubMed ID: 14598186
[TBL] [Abstract][Full Text] [Related]
19. T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer.
Nijman HW; van Diest PJ; Poort-Keesom RJ; von Mensdorff-Pouilly S; Verstraeten RA; Kummer A; Meijer CJ; Melief CJ; Hilgers J; Kenemans P
Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):114-20. PubMed ID: 11134836
[TBL] [Abstract][Full Text] [Related]
20. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
